We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$303M
AUM Growth
+$47.8M
Cap. Flow
+$22.2M
Cap. Flow %
7.34%
Top 10 Hldgs %
34.65%
Holding
115
New
28
Increased
31
Reduced
37
Closed
19

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$9.42M
2
ESRX
Express Scripts Holding Company
ESRX
+$5.8M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$5.1M
4
STJ
St Jude Medical
STJ
+$4.11M
5
BAX icon
Baxter International
BAX
+$4.05M

Top Sells

Rank Stock Value
1
EHC icon
Encompass Health
EHC
+$7.11M
2
UHS icon
Universal Health Services
UHS
+$5.84M
3
DGX icon
Quest Diagnostics
DGX
+$5.57M
4
CYH icon
Community Health Systems
CYH
+$4.33M
5
ELV icon
Elevance Health
ELV
+$4.22M

Sector Composition

Rank Sector Weight
1 Healthcare 87.89%
2 Financials 0.91%
3 Technology 0.66%
4 Consumer Staples 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
76
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$771K 0.25%
+29,700
New +$544K
OCRX
77
DELISTED
Ocera Therapeutics, Inc.
OCRX
$750K 0.25%
159,202
-51,077
-24% -$294K
SYK icon
78
Stryker
SYK
$131B
$747K 0.25%
8,094
-5,900
-42% -$549K
TRNX
79
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$644K 0.21%
24,568
-9,300
-27% -$236K
VTRS icon
80
Viatris
VTRS
$20.5B
$570K 0.19%
9,600
-46,300
-83% -$2.64M
AMAG
81
DELISTED
AMAG Pharmaceuticals
AMAG
$552K 0.18%
+10,100
New +$481K
PBYI icon
82
Puma Biotechnology
PBYI
$391M
$543K 0.18%
2,300
-600
-21% -$128K
BRKR icon
83
Bruker
BRKR
$9.79B
$462K 0.15%
+25,000
New +$474K
SGMO
84
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$428K 0.14%
27,300
-32,000
-54% -$495K
ALR
85
DELISTED
AlerisLife Inc
ALR
$360K 0.12%
+8,110
New +$306K
VIRX
86
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$343K 0.11%
+667
New +$336K
WOOF
87
DELISTED
VCA Inc.
WOOF
$343K 0.11%
6,250
-20,000
-76% -$1.05M
AMGN icon
88
Amgen
AMGN
$204B
$336K 0.11%
+2,100
New +$331K
PMC
89
DELISTED
PharMerica Corporation
PMC
$335K 0.11%
+11,900
New +$296K
ACOR
90
DELISTED
Acorda Therapeutics
ACOR
$313K 0.1%
+78
New +$357K
BDSI
91
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$238K 0.08%
+22,700
New +$310K
DVA icon
92
DaVita
DVA
$15B
$215K 0.07%
2,647
-29,100
-92% -$2.23M
ALGN icon
93
Align Technology
ALGN
$12.4B
$204K 0.07%
+3,800
New +$217K
ARWR icon
94
Arrowhead Research
ARWR
$12.1B
$196K 0.06%
+28,900
New +$205K
LITS
95
Lite Strategy Inc
LITS
$33.4M
$171K 0.06%
4,772
-730
-13% -$65.3K
TEAR
96
DELISTED
TearLab Corporation
TEAR
$61K 0.02%
3,089
-5,476
-64% -$132K
ABBV icon
97
AbbVie
ABBV
$433B
– –
-33,301
Closed -$2.18M
DGX icon
98
Quest Diagnostics
DGX
$25.6B
– –
-83,000
Closed -$5.57M
HRTX icon
99
Heron Therapeutics
HRTX
$96.8M
– –
-58,100
Closed -$584K
MTD icon
100
Mettler-Toledo International
MTD
$29B
– –
-4,100
Closed -$1.24M
1 2 3
4
5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Endurant Capital Management held 115 positions worth $303M, up 19% from $255M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management deployed $22.2M of net new capital in Q1 2015, opening 28 new positions and adding to 31 existing holdings. Its largest new stake was Express Scripts Holding Company: 69,200 shares worth $6M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Encompass Health, an estimated $7.11M trimmed.

  • Endurant Capital Management's largest Q1 2015 buy was Express Scripts Holding Company: 69,200 shares worth $6M.
  • Endurant Capital Management added most to Globus Medical in Q1 2015, an estimated $9.42M increase.
  • Endurant Capital Management's biggest Q1 2015 reduction was Encompass Health, cutting an estimated $7.11M.
  • Endurant Capital Management fully exited Quest Diagnostics in Q1 2015, selling an estimated $5.57M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $303M portfolio in Q1 2015.
  • Endurant Capital Management opened 28 new positions and closed 19 in Q1 2015.
  • Endurant Capital Management's portfolio value rose 19% quarter-over-quarter to $303M.

Based on Endurant Capital Management's 13F filing for Q1 2015, filed 15 May 2015.